Nano, Marmie R.
HRN: 09-56-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
CEFUROXIME 500MG (TAB)
08/14/2025
08/20/2025
PO
500mg
Bid
Cs
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: